PBPH Among Health Care ETFs
End-of-day Nov 16, 2026 · 31 Health care ETFs by 3Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.7% | −0.9% | +7.7% | +10.0% | +24.4% | — | — | — | +25.3% |
| Peer average | −1.5% | −3.2% | +4.0% | +1.6% | +19.6% | +25.3% | +73.9% | +24.7% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$170 of every $1,000 in PBPH is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLY.TOELI Lilly | Healthcare | 16.97% | $1,697.49 | 164K | $233.8M |
| 2 | JNJ.TOJohnson & Johnson | Healthcare | 9.66% | $965.80 | 469K | $133.0M |
| 3 | ABBVAbbvie | Healthcare | 7.35% | $735.12 | 344K | $101.3M |
| 4 | MRKMerck | Healthcare | 5.13% | $513.01 | 481K | $70.7M |
| 5 | —Roche AG | — | 4.87% | $486.63 | 138K | $67.0M |
| 6 | AZN.LAstrazeneca | Healthcare | 4.69% | $469.41 | 351K | $64.7M |
| 7 | AMGNAmgen | Healthcare | 4.37% | $437.21 | 129K | $60.2M |
| 8 | NOVN.SWNovartis Ag-reg | Healthcare | 4.14% | $413.51 | 354K | $57.0M |
| 9 | GILD.TOGilead Sciences | Healthcare | 4.02% | $401.99 | 330K | $55.4M |
| 10 | PFE.BAPfizer | Healthcare | 3.18% | $317.52 | 1.5M | $43.7M |
| 11 | VRTXVertex Pharmaceuticals | Healthcare | 2.64% | $264.12 | 67K | $36.4M |
| 12 | —Novo Nordisk A/s-b | — | 2.51% | $251.45 | 849K | $34.6M |
| 13 | BMYBristol-myers Squibb | Healthcare | 2.46% | $245.92 | 544K | $33.9M |
| 14 | SNYSanofi | Healthcare | 2.03% | $203.44 | 288K | $28.0M |
| 15 | REGNRegeneron Pharmaceuticals | Healthcare | 1.82% | $182.20 | 26K | $25.1M |
Official documents are being connected from SEC EDGAR: […]. Read the issuer’s prospectus before investing.
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 24, 2025 | Dec 26, 2025 | $0.0230 |
of the $114B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY.TO | ELI Lilly & | 16.97% |
| 2 | JNJ.TO | Johnson & Johnson | 9.66% |
| 3 | ABBV | Abbvie | 7.35% |
| 4 | MRK | Merck & | 5.13% |
| 5 | AZN.L | Astrazeneca | 4.69% |
| 6 | AMGN | Amgen | 4.37% |
| 7 | NOVN.SW | Novartis Ag-reg | 4.14% |
| 8 | GILD.TO | Gilead Sciences | 4.02% |
| 9 | PFE.BA | Pfizer | 3.18% |
| 10 | VRTX | Vertex Pharmaceuticals | 2.64% |